Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | NQO2 | P16083 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.46 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.45 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.45 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL74016 | 0.98 | BCHE (0.54) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL29370232 | 0.98 | BCHE (0.54) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| Phosphine SCHEMBL28240080 | 0.96 | BCHE (0.52) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL2586600 | 0.96 | BCHE (0.52) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| Methane SCHEMBL27919120 | 0.94 | BCHE (0.51) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL30040280 | 0.92 | LIPG (0.53) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL4736996 | 0.92 | LIPG (0.53) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL6138964 | 0.92 | LIPG (0.53) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL30269721 | 0.92 | LIPG (0.53) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 | |
| SCHEMBL11779176 | 0.92 | LIPG (0.53) | BCHECYP1A2CYP2C19CYP2D6SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102290-A1 | ENZYMATIC CAUSTIC FREE DETERGENT COMPOSITIONS FOR CLEANING DAIRY PROCESSING SYSTEMS | ECOLAB USA INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260125615-A1 | ENZYMATIC CAUSTIC FREE DETERGENT COMPOSITIONS FOR CLEANING DAIRY PROCESSING SYSTEMS | ECOLAB USA INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20250019619-A1 | SOLID RINSE AID COMPOSITION COMPRISING POLYACRYLIC ACID | ECOLAB USA INC. | 2025-01-16 | — | — | US | claimed |
| US-12134750-B2 | Solidification process using low levels of coupler/hydrotrope | ECOLAB USA INC. (US) | 2024-11-05 | — | — | US | claimed |
| US-20240043774-A1 | SOLIDIFICATION PROCESS USING LOW LEVELS OF COUPLER/HYDROTROPE | ECOLAB USA INC. | 2024-02-08 | — | — | US | claimed |
| CN-116998493-A | Pyridine carboxylic acid and tribenuron-methyl compound composition and preparation method thereof | 镇江先锋植保科技有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-115612687-A | Nucleic acid extraction reagent effervescent tablet by using paramagnetic particle method, preparation method and application thereof | 北京迈佳致和科技有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-112299888-B | Nano selenium nutrient solution and preparation method thereof | 杭州富春硒谷农业科技有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-113604804-B | Etching solution for stabilizing line width loss and etching cone angle in panel copper plating process | 湖北兴福电子材料股份有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-114836119-A | Preparation method of zinc-doped three-dimensional graphene/hierarchical porous carbon water-based anticorrosive paint | 江苏索普聚酯科技有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114609074-A | Method for detecting content of cyclic amine compound in copper etching solution | 江苏和达电子科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-111205823-A | Composite dust suppressant | 南通乐尔环保科技有限公司 | 2020-05-29 | — | — | CN | claimed |
| WO-2011135582-A2 | PHARMACEUTICAL COMPOSITIONS OF DRONEDARONE | CADILA HEALTHCARE LIMITED (IN) | 2011-11-03 | — | — | WO | claimed |
| US-6878180-B2 | Combination ammonium sulfate/drift reducing adjuvant and wet bond process for making the same | EXACTO, INC. (US) | 2005-04-12 | — | — | US | claimed |
| US-20030074940-A1 | Combination ammonium sulfate/drift reducing adjuvant and wet bond process for making the same | EXACTO, INC. | 2003-04-24 | — | — | US | claimed |
| US-5342605-A | For x-ray examination of intestinal tract; forming thin film on mucosal lining; barrier | STERLING WINTHROP INC. (US) | 1994-08-30 | — | — | US | claimed |
| US-5318768-A | For gastrointestinal tract; film membrane, cation potentiator, particle surface modifier | STERLING WINTHROP INC. (US) | 1994-06-07 | — | — | US | claimed |
| WO-2026102290-A1 | ENZYMATIC CAUSTIC FREE DETERGENT COMPOSITIONS FOR CLEANING DAIRY PROCESSING SYSTEMS | ECOLAB USA INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-4133847-A | Vaporized fuel for internal combustion engine and method and apparatus for producing same | FEUERMAN ARNOLD I | 1979-01-09 | — | — | US | disclosed |
| US-4011843-A | Vaporized fuel for internal combustion engine and method and apparatus for producing same | FEUERMAN ARNOLD I | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125615-A1 | ENZYMATIC CAUSTIC FREE DETERGENT COMPOSITIONS FOR CLEANING DAIRY PROCESSING SYSTEMS | CEL, PNLIP, CTRC | BCHE 15/4885CYP1A2 2201/4885CYP2C19 2913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.